ENO1 and neoplasm: The average tumor inhibition rate, calculated based on the final tumor volume of each group, showed that the PPH + PTX group achieved an inhibition rate of approximately 80%, which was significantly superior to the 55% inhibition rate of the lovastatin + PTX group, further supporting the potential advantage of PPH in reversing MDR.